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The objective of this study is to compare aneuploidy rates between three distinct areas of 
the human trophectoderm: mural, polar, and a region in between these two locations termed the 
“mid” trophectoderm.  This is a cohort study on IVF patients undergoing comprehensive 




chromosome screening at the blastocyst stage at a private IVF clinic.  All embryos underwent 
assisted hatching on day 3 with blastocyst biopsy and comprehensive chromosome screening.  
Biopsied blastocysts were divided into three groups depending on which area (polar, mid, or 
mural) of the trophectoderm was protruding from the zona pellucida and biopsied.  Aneuploidy 
rates were significantly higher with cells from the polar region of the trophectoderm (56.2%) 
compared to cells removed from the mural region of the trophectoderm (30.0%; P=0.0243).  A 
comparison of all three areas combined also showed a decreasing trend, but it did not reach clinical 
significance, polar (56.2%), mid (47.4%), and mural trophectoderm (30.0%; P=0.1859).  The non-
concordance demonstrated between polar and mural trophectoderm can be attributed to biological 
occurrences including chromosomal mosaicism or procedural differences between embryologists.
Keywords: Preimplantation genetic screening; aneuploidy; embryo biopsy; comprehensive 
chromosome screening; IVF





Aneuploidy refers to the presence of absence of whole chromosomal abnormalities.  In 
order for a euploid live birth to occur, chromosomes must divide equally in the developing fetus.  
Any abnormal division during development can have disastrous downstream effects, leading to 
poor embryo development, failed implantation, obstetric complications, pregnancy loss, stillbirth, 
neonatal congenital abnormality, and infertility.  Thus, preimplantation genetic testing (PGT) has 
been created to test for aneuploidy prior to implantation thereby allowing the transfer of euploid 
embryos.  The transferring of euploid embryos has demonstrated a higher pregnancy rate, lower 
miscarriage rate, and higher live birth rate than the transfer of untested embryos (Yang et al., 2012; 
Forman et al., 2013; Scott et al., 2013)  Unfortunately, these studies are limited due to good 
prognosis patients or are not based on “intent to treat”.  More recent research has demonstrated 
that embryos diagnosed as mosaic, having a mixture of euploid and aneuploid cell lines, and even 
embryos diagnosed as aneuploid can produce live births (Munne et al., 2017 and Patrizio et al., 
2019). 
The blastocyst represents the first stage of differentiation in preimplantation development.  
The blastocyst differentiates into the inner cell mass (ICM), which will become the fetus and the 
trophectoderm that will become the placenta.  The trophectoderm itself is subdivided into two 
areas based on the location of the ICM: the mural trophectoderm, the area furthest away from the 
ICM, and the polar trophectoderm, the area adjacent to the ICM.  Typically, during PGT cells are 
removed from the mural trophectoderm as not to expose the ICM to the damage caused by the 
laser (Taylor et al., 2014).  However, blastocyst biopsy is not standardized, which can lead to inter 
and intra differences with embryologists in terms of the area of biopsied.




It has been suggested that ploidy is consistent throughout the trophectoderm (i.e. that all 
cells have the same karyotype) (Northrop et al, 2010; Capalbo et al, 2013).  Thus, cells removed 
from the mural trophectoderm should mirror the chromosome content of the remaining cells.  To 
test this hypothesis, this study aimed to compare aneuploidy rates between three distinct areas of 
trophectoderm: mural, polar, and a region in between these two locations termed the “mid” 
trophectoderm.  
Methods
This study was deemed exempt by Sterling IRB because it only incorporated routine IVF 
procedures.  Only patients undergoing in vitro fertilization with PGT between January 2012 and 
April 2013 at Reproductive Endocrinology Associates of Charlotte (Charlotte, North Carolina, 
USA) were included in this study.  All biopsy specimens were sent to Genesis Genetics (Detroit, 
Michigan, USA) where samples underwent next generation sequencing (NGS).
Briefly, all fertilized oocytes were cultured to day 3 and assisted hatching (AH) was 
performed.  Embryos were placed back into incubator and cultured to the blastocyst stage.  
Embryos whose trophectoderm was hatching out of the zona pellucida (ZP) underwent the biopsy 
procedure.  Biopsied blastocysts were divided into three groups depending on which area (polar, 
mid, or mural) of the trophectoderm was protruding from the ZP and was biopsied.
Egg Retrieval and Embryo Culture 
All retrieved oocytes were designated for intracytoplasmic sperm injection (ICSI).  
Oocytes were retrieved, trimmed of blood, and stripped of cumulus cells as described by Taylor 




and colleagues (Taylor et al., 2008).  Oocytes were separated based on maturity and placed into a 
60 mm dish (Thermo scientific, Rochester, New York, USA) with approximately 100 µL drops of 
continuous culture media (CSC; Irvine Scientific, Santa Ana, California, USA) supplemented with 
10% serum substitute supplement (SSS; Irvine Scientific, Santa Ana, California, USA) and 
overlayed with oil (Irvine Scientific, Santa Ana, California, USA).  After grading, the dish 
containing the oocytes was placed into an incubator at 37oC, 6% CO2 and 5% O2 for 2-3 hours.  
After 2 hours, all oocytes presenting with a polar body underwent ICSI’d as described by Nagy 
and colleagues (1995), placed back into the same dish, and put back into the incubator.
The next day, 16-18 hours post ICSI, oocytes were evaluated for proper fertilization.  
Embryos that exhibited two pronuclei were group cultured in a fresh dish of CSC+10%SSS 
overlayed with oil and placed back into the incubator.  Embryos were not viewed on day 2.  
On day 3, the embryos were removed from the incubator, graded, and AH was performed 
on all cleaving embryos with the aid of a laser (Zilos-tk, Hamilton Thorne, Beverly, Mass, USA).  
Using a pulse of 610 µs, the ZP was breached with 2-3 shots of the laser (Zilos-tk, Hamilton 
Thorne, Beverly, Maine, USA).  The ZP was breached where there were no blastomeres that could 
be directly affected by the laser pulse.  After breaching the ZP with the laser, the embryos were 
left in the same drop and placed back into the incubator.
On the morning of day 5 (112-115 hours post insemination) and day 6 (136-139 hours post 
insemination), embryos were removed from the incubator, blastocysts were graded based on 
Schoolcraft and colleagues (1999), and those blastocysts that had a good or fair trophectoderm 
protruding from the ZP along with good or fair quality ICM were biopsied.  Blastocysts were only 
viewed once in the morning and at no other times.  If the blastocysts were not suitable for biopsy 




in the morning of day 5, they were reevaluated on the morning of day 6.  Blastocysts were biopsied 
on day 5 or day 6, which ever day they met the biopsy criteria.  If embryos did not meet the criteria 
for biopsy on day 6, they were discarded.  There was no morphological difference between 
blastocysts that were biopsied on day 5 or day 6 other than the embryos needed an extra day to 
reach the proper stage for biopsy.
Trophectoderm biopsy
Blastocysts that presented with a good or fair quality ICM and trophectoderm were placed 
in a drop of modified human tubal fluid (Irvine scientific, Santa Ana, California, USA) + 10% SSS 
(Irvine scientific, Santa Ana, California, USA).  Suction was applied to the blastocysts via a 
holding pipette (Humagen, Charlottesville, Virginia, USA).  A biopsy pipette (Humagen, 
Charlottesville, Virginia, USA) gently aspirated the trophectoderm into the biopsy needle.  A laser 
(Zilos-tk, Hamilton Thorne, Beverly, Maine, USA), with a pulse length of 610µm, was used to 
“cut” the trophectoderm from the blastocyst, taking care not to expose the trophectoderm to 
unnecessary laser pulses.  The piece of trophectoderm was prepped for next generation sequencing.
Results
In total, 166 blastocysts were biopsied, 48 from the polar trophectoderm, 78 from the mid 
trophectoderm, and 40 from the mural trophectoderm.  There was no significant difference in 
maternal age between the three groups, i.e. 35.8±4.9 years, 34.9±4.4 years, and 35.2±5.1 years, for 
the plural, mid, and mural trophectoderm, biopsied groups respectively (Table 1; P=0.8024).  
Aneuploidy rates were 27/48 in polar trophectoderm group (56.2%), 37/78 in the mid 
trophectoderm group (47.4%), and 12/40 in the mural trophectoderm group (30.0%; Table 1; 




P=0.1859).  In a direct comparison between mural and polar trophectoderm, aneuploidy rates were 
significantly higher (Table 2; P=0.0243).  
Discussion
The hypothesis that aneuploidy is evenly distributed throughout the trophectoderm cannot 
be supported by this study.  Aneuploidy rates were significantly higher when cells were taken from 
the polar region of the trophectoderm (56.2%) compared to cells removed from the mural region 
of the trophectoderm (30.0%; Table 2).  These data also demonstrates a strong trend in decreasing 
aneuploidy from the polar (56.2%), mid (47.4%), and mural trophectoderm (30.0%; Figure 1).  
The non-concordance demonstrated between polar and mural trophectoderm can be attributed to 
biological occurrences or procedural differences.
Biologically, Hogan and Tilly (Hogan and Tilly, 1978) dissected mouse ICM from the 
trophectoderm and left the ICM in culture.  Within five days, some of the individual ICM’s had 
the appearance of a blastocyst.  Moreover, the individual ICM’s derived trophoblast giant cells.  
These studies suggest that cells from the ICM feed the trophectoderm.  It is unknown if this 
mechanism is present in human embryos; however, if it were, it could explain these data.  If the 
ICM were mosaic and contained equal proportions of aneuploid and euploid cells, then aneuploid 
cells would feed into the trophectoderm at the same rate as euploid cells.  Once in the 
trophectoderm, the euploid cells would proliferate at a faster rate than aneuploid cells 
(Ruangvutilert et al.., 2000).  Thus, the blastocyst could have a higher proportion of aneuploid 
cells in the polar compared to the mural trophectoderm, which these data supports (Figure 2).  
Conversely, this theory would suggest that the blastocyst may be able to allocate aneuploid cells 




to the trophectoderm thereby correcting its chromosome state by the elimination of aneuploid cells 
from the ICM.  Research using FISH and array-based techniques have found no evidence of this 
correction mechanism in place for human blastocysts (Johnson et al., 2000; Northrop et al., 2010; 
Evsikov and Verlinsky, 1998; Derhaag et al., 2003; Fragouli et al., 2008).
Another biological reason for the discrepancy between regions of the trophectoderm could 
be the blastocyst preparing for implantation.  During implantation, the blastocyst embeds itself 
with the ICM (polar trophectoderm) against the uterine wall.  In order to invade into the uterine 
wall, the cytotrophoblasts, which are located in the polar region, have been shown to induce 
aneuploidy (Weier et al, 2005).  These data suggests that aneuploidy is higher in the polar region, 
possibly because the embryo is undergoing chromosomal changes to prepare for implantation.  
Unfortunately this study did not examine implantation rates between the three different categories, 
so it is unknown if aneuploidy in the polar region is detrimental.  However, transfers of “aneuploid” 
or mosaic blastocysts have resulted in euploid live births suggesting that some aneuploidy and 
mosaicism may not be clinically significant (Scott et al., 2012; Greco et al., 2015; Taylor et al., 
2014; Munne et al., 2017; Patrizio et al., 2019).  Both of these biological occurrences suggest that 
mosaicism is a common phenomenon within the human blastocyst (Taylor et al., 2014b).  
Literature is currently lacking in terms of the effects of the biopsy procedure on the 
outcomes of PGT cycles.  For example, in this study, the embryologist has to biopsy from the 
mural trophectoderm.  Because of its proximity to the ICM, it is possible that some ICM cells were 
removed with the trophectoderm during the biopsy.  Unfortunately, the level of contamination 
between the ICM and trophectoderm during the biopsy is unknown.  However, this may not affect 
the PGT result as research has indicated a high concordance between the two regions (Johnson et 
al, 2000; Capalbo et al, 2013).  Interestingly, with the advent of NGS and its increase in the 




detection of mosaicism, the biopsy procedure has become a variable.  If embryologist “A” biopsies 
two cells from the blastocyst and both are normal or abnormal, mosaicism will not be detected.  
However, if embryologist “B” biopsies 10 cells from the blastocyst and six cells are aneuploid and 
four cells are euploid, mosaicism will be detected simply due to the increase number of cells 
biopsied.  Research has also suggested that the majority of abnormalities at the blastocyst stage 
are mitotic in origin, suggesting that with enough cells present, PGT results could be altered 
(McCoy et al., 2015).
Ideally, one should biopsy from the polar, mid, and mural trophectoderm from a single 
blastocyst; however, this was not possible because these were patients undergoing IVF and not 
blastocysts donated to research.  Northrop and colleagues (2010) examined three separate 
trophectoderm sections from the same blastocyst and demonstrated a concordance rate of 80% 
(40/50 blastocysts), but this study did not record the location of the trophectoderm samples in 
relation to the ICM.   Another limitation was performing AH on day 3.  AH allows for premature 
hatching which may disrupt the true chromosomal makeup within the embryo or influence cell 
distribution.  It is possible that the heat generated from the laser could disrupt cell junctions and 
impact further embryological development, possibly allowing for the premature expulsion of cells 
(White et al., 2018).  However, research in the mouse demonstrates that embryos hatch equally 
from the polar, mid, and mural trophectoderm, suggesting a limited impact on the AH procedure 
(Schimmel et al., 2014).  Our data is similar, of the 166 blastocysts, there was no difference 
between which area (polar, mid, or mural) hatched out of the blastocyst, 37.8%, 30.7%, 31.5%, 
respectively (P=NS).  Further research is needed whereby AH is not performed and blastocysts are 
not exposed to the laser until biopsy, day 5 or 6.  




Most of the research with mosaicism at the blastocyst stage deals with the reanalysis of 
array comparative genomic hybridization samples or the mixing of known cell lines to determine 
the percent mosaicism present in the entire blastocyst (Ruttanajit et al., 2016).  The only way we 
can understand aneuploidy and blastocyst morphology is to isolate individual cells within the 
blastocyst and effectively “map” the cells, creating a virtual image of the blastocyst (Taylor et al., 
2016).  This study has already been performed and although cost prohibitive, larger studies are 
certainly warranted. 
In conclusion, these data do not support the hypothesis that aneuploidy is evenly distributed 
throughout the trophectoderm.  This study adds to the pool of data that may help patients and 
clinicians understand why some embryos diagnosed as “euploid” fail to implant.  Further research 
is needed to better understand aneuploidy at the blastocyst stage and its clinical consequences.
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Table 1: A comparison of aneuploidy rates between the polar, mid, and mural trophectoderm.
1 Kruskal-Wallis test                  2 Chi-square test
Polar Mid Mural P value
Avg. Age (years) 35.8±4.9 34.9±4.4 35.2±5.1 0.80241
No. Blastocyst 48 78 40
No. Aneuploid 27 (56.2%) 37 (47.4%) 12 (30.0%) 0.1859
2




Table 2: A comparison of aneuploidy rates between polar and mural trophectoderm.
Polar Mural P Value
Avg. Age 35.8±4.9 35.2±5.1 0.84171
No. Blastocyst 48 40
No. Aneuploidy 27 (56.2%) 12 (30.0%) 0.0243
2
1 Kruskal-Wallis test               2 Chi-square test




Figure 1: Aneuploidy rates between polar, mid, and mural trophectoderm.




Figure 2: A figure showing the direction of cellular migration from the inner cell mass out into the 
trophectoderm.
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